W. Bolanowska

788 total citations
22 papers, 687 citations indexed

About

W. Bolanowska is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Organic Chemistry. According to data from OpenAlex, W. Bolanowska has authored 22 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Health, Toxicology and Mutagenesis and 4 papers in Organic Chemistry. Recurrent topics in W. Bolanowska's work include Biochemical and Molecular Research (4 papers), Heavy Metal Exposure and Toxicity (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). W. Bolanowska is often cited by papers focused on Biochemical and Molecular Research (4 papers), Heavy Metal Exposure and Toxicity (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). W. Bolanowska collaborates with scholars based in United States, Poland and Switzerland. W. Bolanowska's co-authors include Justyna M. Wiśniewska-knypl, Jerzy K. Piotrowski, B Trojanowska, Andrzej Sapota, Teresa Gessner, John J. McGuire, HD Preisler, James K. Coward, J. Piotrowski and Barry Hart and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

In The Last Decade

W. Bolanowska

22 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Bolanowska United States 13 311 270 155 123 67 22 687
Hans‐Jürgen Hartmann Germany 20 257 0.8× 469 1.7× 249 1.6× 186 1.5× 78 1.2× 34 927
Noriyuki Shiraishi Japan 19 357 1.1× 451 1.7× 330 2.1× 70 0.6× 26 0.4× 45 935
Kimberley A. O’Hara Canada 16 215 0.7× 94 0.3× 378 2.4× 91 0.7× 66 1.0× 24 845
Robert D. Andersen United States 16 566 1.8× 616 2.3× 334 2.2× 137 1.1× 15 0.2× 20 1.2k
Malay Chatterjee India 15 115 0.4× 193 0.7× 202 1.3× 59 0.5× 26 0.4× 22 611
Frederick W. Benz United States 10 110 0.4× 168 0.6× 125 0.8× 62 0.5× 31 0.5× 18 400
Michael D. Stonard United Kingdom 16 286 0.9× 154 0.6× 200 1.3× 84 0.7× 18 0.3× 28 776
A. Barbin France 18 270 0.9× 100 0.4× 633 4.1× 129 1.0× 116 1.7× 24 1.3k
Luigi Robbiano Italy 22 326 1.0× 38 0.1× 390 2.5× 84 0.7× 89 1.3× 70 1.3k
Caigao Zhong China 18 262 0.8× 122 0.5× 235 1.5× 43 0.3× 23 0.3× 28 663

Countries citing papers authored by W. Bolanowska

Since Specialization
Citations

This map shows the geographic impact of W. Bolanowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Bolanowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Bolanowska more than expected).

Fields of papers citing papers by W. Bolanowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Bolanowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Bolanowska. The network helps show where W. Bolanowska may publish in the future.

Co-authorship network of co-authors of W. Bolanowska

This figure shows the co-authorship network connecting the top 25 collaborators of W. Bolanowska. A scholar is included among the top collaborators of W. Bolanowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Bolanowska. W. Bolanowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McGuire, John J., Barry Hart, Myung S. Rhee, et al.. (1996). Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (γ-glutamate) metabolites. Biochemical Pharmacology. 52(8). 1295–1303. 6 indexed citations
2.
3.
McGuire, John J., et al.. (1994). Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.. PubMed. 54(10). 2673–9. 8 indexed citations
4.
McGuire, John J., et al.. (1991). Biochemical and biological properties of methotrexate analogs containing d-glutamic acid or d-erythro,threo-4-fluoroglutamic acid. Biochemical Pharmacology. 42(12). 2400–2403. 9 indexed citations
5.
6.
Bolanowska, W., et al.. (1990). Activation of mammalian folylpolyglutamate synthetase by sodium bicarbonate. Archives of Biochemistry and Biophysics. 281(2). 198–203. 9 indexed citations
7.
McGuire, John J., et al.. (1990). Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.. PubMed. 50(6). 1726–31. 28 indexed citations
8.
McGuire, John J., W. Bolanowska, & James R. Piper. (1988). Structural specificity of inhibition of human folylpolyglutamate synthetase by ornithinecontaining folate analogs. Biochemical Pharmacology. 37(20). 3931–3939. 17 indexed citations
9.
Gessner, Teresa, HD Preisler, N. Azarnia, et al.. (1987). Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy. Medical Oncology and Tumor Pharmacotherapy. 4(1). 23–31. 10 indexed citations
10.
Bolanowska, W., et al.. (1986). Isolation and Characterization of a Novel Nucleoside from Human Cancer Urine. Nucleosides and Nucleotides. 5(3). 253–263. 6 indexed citations
11.
Gessner, Teresa, N. Azarnia, W. Bolanowska, et al.. (1984). Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia. Cancer Chemotherapy and Pharmacology. 12(2). 125–30. 53 indexed citations
12.
Bolanowska, W., Teresa Gessner, & HD Preisler. (1983). A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography. Cancer Chemotherapy and Pharmacology. 10(3). 187–91. 35 indexed citations
13.
Bolanowska, W. & Teresa Gessner. (1982). Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice. Xenobiotica. 12(2). 125–136. 14 indexed citations
14.
Paigen, Beverly, Elizabeth Ward, Kyle Steenland, et al.. (1982). Absence of seasonal variation in antipyrine metabolism. Clinical Pharmacology & Therapeutics. 31(2). 144–150. 2 indexed citations
15.
Bolanowska, W. & Teresa Gessner. (1980). Drug interactions with acetaminophen. Biochemical Pharmacology. 29(8). 1167–1175. 3 indexed citations
16.
Gurtoo, Hira L., Jimmie B. Vaught, Anthony J. Marinello, et al.. (1980). High-pressure liquid chromatographic analysis of benzo(a)pyrene metabolism by human lymphocytes from donors of different aryl hydrocarbon hydroxylase inducibility and antipyrine half-lives.. PubMed. 40(4). 1305–10. 10 indexed citations
17.
Bolanowska, W. & Teresa Gessner. (1978). Drug interactions: inhibition of acetaminophen glucuronidation by drugs.. Journal of Pharmacology and Experimental Therapeutics. 206(1). 233–238. 29 indexed citations
18.
Bolanowska, W., et al.. (1973). Evaluation of metallothionein content in animal tissues.. PubMed. 20(3). 207–15. 127 indexed citations
19.
Bolanowska, W. & Justyna M. Wiśniewska-knypl. (1971). Dealkylation of tetraethyllead in the homogenates of rat and rabbit tissues. Biochemical Pharmacology. 20(8). 2108–2110. 18 indexed citations
20.
Bolanowska, W., et al.. (1967). Triethyllead in the biological material in cases of acute tetraethyllead poisoning. PubMed. 22(4). 278–282. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans‐Jürgen Hartmann Breakdown of academic impact, for papers by Noriyuki Shiraishi Breakdown of academic impact, for papers by Kimberley A. O’Hara Breakdown of academic impact, for papers by Robert D. Andersen Breakdown of academic impact, for papers by Malay Chatterjee Breakdown of academic impact, for papers by Frederick W. Benz Breakdown of academic impact, for papers by Michael D. Stonard Breakdown of academic impact, for papers by A. Barbin Breakdown of academic impact, for papers by Luigi Robbiano Breakdown of academic impact, for papers by Caigao Zhong
Rankless by CCL
2026